BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Events//NONSGML v1.0//EN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART;TZID="Pacific Time (US & Canada)":20251006T161000
DTEND;TZID="Pacific Time (US & Canada)":20251006T170000
SUMMARY:Department of Chemistry Seminar – Dr. Rajappa Vaidyanathan
LOCATION:Fulmer Hall
DESCRIPTION:Speaker: Dr. Rajappa Vaidyanathan\n\nHost: Rishi Sharma\n\nTitle: Development of Robust, Sustainable Chemical Processes for the Rapid Delivery of Drug-Linkers\n\nAbstract: Antibody-drug conjugates (ADCs) are a class of cancer drugs that combine the targeting ability of monoclonal antibodies with the cell-killing power of cytotoxic drugs. A typical ADC consists of a monoclonal antibody (mAb) covalently attached to a Drug-Linker molecule (i.e. cytotoxic drug attached to a chemical linker).  ADCs are designed to selectively deliver potent chemotherapy to cancer cells, minimizing damage to healthy tissues.\n\nThis talk will describe the development of innovative chemical processes that can reliably produce large quantities of Drug-Linkers to support clinical trials as well as commercial supply.  Specifically, techniques used to accelerate process development (and consequently, availability of drug to patients) will be described, and illustrated with several examples.
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:REMINDER
TRIGGER;RELATED=START:-PT00H15M00S
END:VALARM
END:VEVENT
END:VCALENDAR